More on INBX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $126.70 |
|
|||
| Open | $126.70 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $126.70 | ||||
| Day Low | $126.70 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,548 | ||||
- Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens as Ozekibart Ph1 Started
- H.C. Wainwright Starts Inhibrx Biosciences (INBX) at Buy
- Inhibrx Biosciences (INBX) Reiterated at Buy by Stifel After Meet with CEO, CFO
- Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
- Form SCHEDULE 13G Inhibrx Biosciences, Filed by: Schonfeld Strategic Advisors LLC
- Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Form 8-K Inhibrx Biosciences, For: Aug 13
- Inhibrx Reports Second Quarter 2026 Financial Results
- Form 10-Q Inhibrx Biosciences, For: Jun 30
Entities mentioned with INBX
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Viking Global Investors | View Related Stories »
- IPO | View Related Stories »
- Show More...
